Uncategorised - European Medical Journal

Continue
17th October 2013

Managing Thromboembolic Risks of Atrial Fibrillation: Can We Afford Increased Efficacy of the Novel Anticoagulants and Devices?

Ischaemic/embolic complications are the most common severe consequences of atrial fibrillation. Although chronic anticoagulation with warfarin has been…
17th October 2013

Atrial Fibrillation in Childhood with Familial Hyperthyroidism in Afro-Caribbeans

Atrial fibrillation (AF) associated with familial hyperthyroidism (FH) spanning three generations concomitantly, is rare. The index case was 10 years old…
17th October 2013

Consistency Versus Equity – Cardiovascular Disease Management For South Asians in the United Kingdom

An increased risk of coronary heart disease was an immediate healthcare concern following the mass arrival of South Asian immigrants to the UK, and it…
17th October 2013

Prescribing Physical Activity for the Prevention and Treatment of Hypertension in Patients with Aortic Coarctation - A Review

Patients who have been treated for aortic coarctation (CoA) have increased late cardiovascular morbidity and mortality, which is partly due to the…
17th October 2013

Initial Evidence in Thromboangiitis Obliterans (Buerger’s Disease) Treatment with Bosentan

Thromboangiitis obliterans (TAO) is a vascular disease that affects small and medium-sized arteries and veins of both upper and lower extremities. Distal…
17th October 2013

Nationwide Family Studies of Cardiovascular Diseases - Clinical and Genetic Implications of Family History

Studies of family history (FH) have long been used to estimate the heritability of cardiovascular diseases (CVDs). Genome-wide association studies (GWAS)…
17th October 2013

The Benefits of Rivaroxaban (Xarelto®) Across Multiple Indications and the Relevance to Cardiologists

Oral anticoagulation with vitamin-K-antagonists has well known limitations and requires routine clinical monitoring of coagulation parameters. The new…
1st October 2013

Poor Asthma Control, Device Handling and Phenotype

The aim of this symposium is to discuss the impact of poor treatment and poor inhaler technique on asthma outcomes. In addition, the symposium will…
1st October 2013

Long-Term Non-Invasive Ventilation (NIV) for COPD Patients with Chronic Respiratory Failure

Chronic obstructive pulmonary disease (COPD) is a major health issue worldwide, with disease burden, healthcare costs, and mortality rates all…
1st October 2013

Effectiveness of Inhaler Devices in Adult Asthma and COPD

Inhalation therapy remains the cornerstone of treatment for bronchial diseases. Despite being pharmacologically efficacious, currently available inhaled…